SELUMETINIB

CHEBI:CHEBI_752065

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
2289428
generic_name
Selumetinib Sulfate
product_type
BULK INGREDIENT
marketing_category
BULK INGREDIENT
listing_expiration_date
20251231
route
ORAL
dosage_form
CAPSULE
active_ingredient_strength
1 kg/kg
package_marketing_start_date
16-APR-20
nui
N0000193944
pharm_class_epc
Kinase Inhibitor [EPC]
pharm_class
Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]
marketing_start_date
20200416
labeler_name
Chunghwa Chemical Synthesis & Biotech Co., Ltd.
manufacturer_name
AstraZeneca Pharmaceuticals LP
active_ingredient_name
SELUMETINIB SULFATE
brand_name
KOSELUGO
brand_name_base
KOSELUGO
product_ndc
52076-6278
application_number
NDA213756
spl_id
ffc8ccb8-929f-8a6f-e053-6294a90ae29b
package_ndc
52076-6278-1
package_description
50 kg in 1 DRUM (52076-6278-1)
unii
6UH91I579U
spl_set_id
7d042c61-f28f-4ab5-ab10-d7558c0d49ff
pharm_class_moa
Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA]
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class